Xeris Biopharma Holdings, Inc.
Public company- Headquarters
- CHICAGO, Illinois
- Ticker
- XERS
- CIK
- 0001867096
WARN notices since 2024
0
None on record
Workers affected since 2024
0
Across 0 notices
Executive changes, last 12 months
1
1 appointment, 0 departures
Last event
Nov 2, 2026
Executive appointmentClass II director appointed: Menassie Taddese
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| Class II directorMenassie Taddese | Nov 2, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- ABBOTT LABORATORIES
Plant closure: CA
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- JOHNSON & JOHNSON
WARN notice: New Brunswick, NJ
- Merck & Co., Inc.
WARN notice: Rahway, NJ
- Executive appointment
Class II director appointed: Menassie Taddese
Menassie Taddese was named Class II director of Xeris Biopharma Holdings, Inc., effective November 2, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Nov 2, 2026Role: Class II director
Only one public record so far. We add events as soon as a new filing lands; watch Xeris Biopharma Holdings, Inc. to get them in your digest.
Last verified Nov 8, 2026